# OnCo record teniposide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/teniposide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "teniposide" ;
  schema:name "Teniposide"@en ;
  schema:alternateName "VM-26"@en, "Vumon" ;
  schema:description "Teniposide is a close relative of etoposide approved in the United States in 1992 for children whose acute lymphoblastic leukaemia has come back after induction, and used in Europe for childhood brain tumours and neuroblastoma."@en ;
  schema:url <https://onco.cc/drugs/teniposide/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Teniposide> ;
  schema:citation <https://en.wikipedia.org/wiki/Teniposide>, <https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1200604> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Podophyllotoxin topoisomerase II inhibitor, intravenous" ;
  onco:approval "US 1992: Refractory childhood acute lymphoblastic leukaemia, in combination induction" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/neuroblastoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/top2a/> ;
  onco:drugs <https://onco.cc/drugs/etoposide/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:trials <https://onco.cc/trials/nct07583511/>, <https://onco.cc/trials/nct07188441/>, <https://onco.cc/trials/nct01700946/> .